Missione Aziendale
Galileo Research is an Italian biotech company with a R&D pipeline strongly focused on oncology and CNS, founded on a solid I.P. background with valuable national and international partnerships. Galileo Research’s mission is to create an appropriate structure to support R&D activities and new therapeutic strategies for pathologies where medical needs are still unmet.
The enterprise model is different from the average virtual company built on the need to exploit I.P. assets only through outsourcing. Galileo Research is a company based in an Italian Research Centre, GLP approved by the Italian Health Authorities since the early nineties, with the experience and expertise of researchers who have for years contributed to the success of Italian firms such as Istituto Gentili and Abiogen Pharma.
G. R. embodies the continuation of an industrial path taken in Abiogen Pharma, where the internal R&D Business Unit represented the pulsating heart in terms of energy and innovation and now this heart will continue to pulsate in a different and more focused corporate environment, where the potential of the project pipeline can gain maximum benefit from scientific and financial opportunities.
G.R. will have unconditional independence from Abiogen Pharma through the availability of a management team of high reputation with a track record of success in R&D management, supported by an outstanding Scientific Board.